Frequency of mutations in individuals with breast cancer referred for <scp><i>BRCA</i></scp><i>1</i> and <scp><i>BRCA</i></scp><i>2</i> testing using next‐generation sequencing with a 25‐gene panel

Abstract

Using an NGS 25-gene panel, the frequency of mutations in genes other than BRCA1/2 was 4.3%, and most mutations (3.9%) were identified in genes associated with breast/ovarian cancer.